Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFsBenzinga • 09/18/25
FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock.Investors Business Daily • 09/16/25
Hims & Hers Expands AI and Technology Focus to Advance Digital CareZacks Investment Research • 09/16/25
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's WhyZacks Investment Research • 09/15/25
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers PlatformGlobeNewsWire • 09/10/25
Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized TreatmentsBusiness Wire • 09/10/25
Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.Market Watch • 09/09/25
Hims & Hers Expanding Partnerships to Build a Global Health EcosystemZacks Investment Research • 09/08/25
HIMS' Personalized Wellness Platform Expands Preventive Care AccessZacks Investment Research • 09/02/25